Share

Jazz Pharmaceuticals buys GW Pharma for $7.2 billion

Jazz Pharmaceuticals is buying GW Pharma for $7.2 billion in cash and stock, or $220 per share. CNBC's Becky Quick reports.
00:56
Wed, Feb 3 20218:39 AM EST